SEBI Bars Seven Family Members in Social Media Stock PumpandDump Case Alleges 2025 Crore Illegal Gains Vickers Stock Research Releases Top Insider Picks for May 26 2026 Compass COMP Stock Under 15 Market Perspectives and Key Considerations Krispy Kreme 16M Data Breach Settlement Deadline Approaches Who Is Eligible Gold Prices Dip as Feds Waller Flags Potential Rate Hike Amid Iran Energy Shock Intel Urges PC Makers to Embrace Advanced 18A Processors as AIDriven Semiconductor Demand Surges ROP Q1 2026 Earnings EPS Beat Driven by Operational Strength Amid Modest Market Response HYPD Q1 2026 Earnings Significant EPS Miss Sends Shares Lower AWK Q1 2026 Earnings EPS Falls Short Shares Slip Slightly QLYS Q1 2026 Earnings EPS Surpasses Estimates by 62 Despite Slight Stock Decline MDGL Q1 2026 Earnings Narrower Loss Surpasses Expectations Amid No Revenue Reported SOJE Q1 2026 Earnings Southern Company Beats EPS Estimates as Utility Operations Remain Stable NewtekOne Inc NEWT Edges Higher as Shares Approach Resistance Zone Great Elm Group Notes GEGGL Steady at 2454 as FixedIncome Investors Seek Yield Calisa Acquisition Corp Right ALISR Holds Steady at 056 as Support and Resistance Levels Tighten NanoViricides NNVC Surges 136 as Stock Approaches Key Resistance Xencor Inc XNCR Holds Near Support as Biotech Sector Shows Mixed Signals Lucid Motors Speculated as Potential Robotaxi Player TAK Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively Broadridge Financial Solutions BR Holds Steady Near 147 as Consolidation Continues Freedom Holding Corp FRHC Q1 2026 Earnings Solid EPS Reported Amid Quiet Disclosure Shares Slip Nathans Famous Q4 2024 Earnings EPS of 096 Reported Stock Edges Lower IRIX Q1 2026 Earnings NarrowerthanExpected Loss Signals Operational Discipline SAQ Q1 2026 Earnings Steep EPS Miss Clouds Outlook for BDC BZAI Q1 2026 Earnings NarrowerthanExpected Loss EPS Beat Signals Operational Progress BLX Q1 2026 Earnings Solid EPS Performance Amid Market Volatility Ernexa Therapeutics ERNA Q3 2023 Earnings Deepening Losses and ClinicalPhase Uncertainty Weigh on Shares